- Home
- TOMZ vs CRIS Comparison
TOMZ vs CRIS Comparison
Compare TOMZ & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TOMZ | CRIS |
|---|---|---|
| Founded | 1979 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5M | 14.0M |
| IPO Year | 2009 | 2000 |
Fundamental Metrics
Financial Performance| Metric | TOMZ | CRIS |
|---|---|---|
| Price | $0.64 | $0.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $3.50 | ★ $16.50 |
| AVG Volume (30 Days) | ★ 216.1K | 117.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.21 |
| EPS | ★ N/A | N/A |
| Revenue | $7,738,842.00 | ★ $9,898,000.00 |
| Revenue This Year | N/A | $6.13 |
| Revenue Next Year | $68.67 | $7.86 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 5.23 | ★ 31.50 |
| 52 Week Low | $0.54 | $0.77 |
| 52 Week High | $1.20 | $3.18 |
Technical Indicators
Market Signals| Indicator | TOMZ | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 40.89 | 41.08 |
| Support Level | $0.54 | $0.95 |
| Resistance Level | $0.81 | $1.04 |
| Average True Range (ATR) | 0.06 | 0.07 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 45.14 | 12.75 |
Price Performance
Historical ComparisonAbout TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.